Cargando…
Cell death in sepsis: a matter of how, when, and where
Dysregulated cell death in several tissues is intimately involved in the pathogenesis of sepsis and contributes to multiple organ failure. Whether cell death during sepsis occurs by necrosis or apoptosis may depend on the cell type as well as the disease stage and is therefore a matter of intense de...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750164/ https://www.ncbi.nlm.nih.gov/pubmed/19678906 http://dx.doi.org/10.1186/cc7966 |
_version_ | 1782172217691340800 |
---|---|
author | Bantel, Heike Schulze-Osthoff, Klaus |
author_facet | Bantel, Heike Schulze-Osthoff, Klaus |
author_sort | Bantel, Heike |
collection | PubMed |
description | Dysregulated cell death in several tissues is intimately involved in the pathogenesis of sepsis and contributes to multiple organ failure. Whether cell death during sepsis occurs by necrosis or apoptosis may depend on the cell type as well as the disease stage and is therefore a matter of intense debate. While lymphocyte apoptosis contributes to immunosuppression in sepsis, recent evidence suggests that necrosis of hepatocytes predominates in septic patients with liver dysfunction and correlates with poor survival. These distinct modes of cell death might have different consequences for the inflammatory response but are also critical for therapeutic interventions and the disease outcome. Understanding the complexity of death processes employing recently available serum biomarkers of cell death could lead to novel therapeutic approaches and assist in the steering of sepsis treatment. |
format | Text |
id | pubmed-2750164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27501642010-07-31 Cell death in sepsis: a matter of how, when, and where Bantel, Heike Schulze-Osthoff, Klaus Crit Care Commentary Dysregulated cell death in several tissues is intimately involved in the pathogenesis of sepsis and contributes to multiple organ failure. Whether cell death during sepsis occurs by necrosis or apoptosis may depend on the cell type as well as the disease stage and is therefore a matter of intense debate. While lymphocyte apoptosis contributes to immunosuppression in sepsis, recent evidence suggests that necrosis of hepatocytes predominates in septic patients with liver dysfunction and correlates with poor survival. These distinct modes of cell death might have different consequences for the inflammatory response but are also critical for therapeutic interventions and the disease outcome. Understanding the complexity of death processes employing recently available serum biomarkers of cell death could lead to novel therapeutic approaches and assist in the steering of sepsis treatment. BioMed Central 2009 2009-07-31 /pmc/articles/PMC2750164/ /pubmed/19678906 http://dx.doi.org/10.1186/cc7966 Text en Copyright ©2009 BioMed Central Ltd |
spellingShingle | Commentary Bantel, Heike Schulze-Osthoff, Klaus Cell death in sepsis: a matter of how, when, and where |
title | Cell death in sepsis: a matter of how, when, and where |
title_full | Cell death in sepsis: a matter of how, when, and where |
title_fullStr | Cell death in sepsis: a matter of how, when, and where |
title_full_unstemmed | Cell death in sepsis: a matter of how, when, and where |
title_short | Cell death in sepsis: a matter of how, when, and where |
title_sort | cell death in sepsis: a matter of how, when, and where |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750164/ https://www.ncbi.nlm.nih.gov/pubmed/19678906 http://dx.doi.org/10.1186/cc7966 |
work_keys_str_mv | AT bantelheike celldeathinsepsisamatterofhowwhenandwhere AT schulzeosthoffklaus celldeathinsepsisamatterofhowwhenandwhere |